Pilonidal Cyst and Body Weight: What the Evidence Shows

A pilonidal cyst is a painful, often infected pocket in the cleft at the top of the buttocks, usually with trapped hair inside. Higher body weight is one of several risk factors for getting it, though the studies do not all agree ^[1][2]. The clearer link is after surgery: people who are overweight have more wound infections ^[7], and wound infections are tied to the cyst coming back ^[8]. No trial has tested whether losing weight prevents pilonidal disease or its return, and no published study has looked at GLP-1 drugs for it.

The honest summary

• Higher BMI is linked to pilonidal disease, but it is one factor among several. A 2025 meta-analysis found higher BMI, long hours of sitting, dense body hair, family history and poor hygiene were all associated with the disease, and a genetic analysis supported BMI as a contributor ^[1].
• Not every study finds the link. In 419 patients compared with matched controls, average BMI was nearly identical (26.0 vs. 25.6) ^[2]. In a 2025 case-control study of men, BMI was not an independent factor once sitting at work, cleft shape and hair were counted ^[3].
• Weight matters most for healing after surgery. In 774 surgical patients, being overweight carried 1.9 times the odds of a wound infection ^[7]. An older study also found obesity was an independent risk factor for infection after excision and closure ^[6].
• Infection and wound breakdown predict recurrence. In 1,662 patients from 41 hospitals, prior recurrence, wound infection and wound separation were independently tied to the disease coming back ^[8].
• Weight loss has not been tested, and GLP-1 drugs have no pilonidal data. Some surgeons advise losing weight before an elective operation ^[6], but that advice rests on the infection link, not on a trial.

What a pilonidal cyst actually is

Despite the name, a pilonidal cyst is usually not a true cyst. Doctors more often call it pilonidal sinus disease: a chronic tract or pocket in the soft tissue of the natal cleft, the crease between the buttocks just above the tailbone. Trapped hair inside the lesion is its signature. It can show up suddenly as a painful abscess, or as a small opening that drains on and off and seems to heal before flaring again ^[1].

It is mostly a disease of young adults. In Western countries the incidence is roughly 26 per 100,000 people, mainly between ages 15 and 30, and men are about four times as likely to get it as women ^[1]. The usual explanation is mechanical: hair, pressure and friction in a deep, moist crease push hair into the skin, which then triggers inflammation.

Is body weight a risk factor for getting one?

Probably, modestly. The largest synthesis so far, a 2025 systematic review and meta-analysis, pooled observational studies and found BMI was higher in people with pilonidal disease than in controls across eight studies ^[1]. The same review ran a Mendelian randomization analysis, a method that uses genetic variants as a natural experiment to reduce confounding, and it also linked higher BMI to higher risk. The authors propose that a deeper, narrower cleft at higher weight traps sweat and limits airflow.

That conclusion comes with caveats the authors state themselves. The studies were heterogeneous, more than half came from Turkey, and the genetic analysis used only European populations. The genetic result also speaks to lifelong, inherited tendency toward higher BMI, not to what happens if a given person loses weight ^[1]. Dense body hair was also a clear risk factor, with about 3.3 times the odds of disease.

Individual studies show why the question has been argued for decades. A Turkish study of 419 surgical patients and 213 age- and sex-matched controls found almost no difference in average BMI (26.0 vs. 25.6) and only 2% obesity in each group, concluding that obesity alone is not an important cause ^[2]. A 2025 Dutch case-control study of 83 men with the disease and 83 controls found that after adjusting for other factors, only working in a sitting position, a shallower cleft and more hair in the cleft were independent risk factors; BMI was not among them ^[3].

Does weight affect recurrence after surgery?

Recurrence is the problem that frustrates people most, and the weight evidence here is genuinely split. In 114 patients treated with a Limberg flap, the six who had a recurrence had a higher average BMI (29.35) than those who did not (27.4), and patients referred in with recurrent disease were heavier than those with a first episode ^[4]. But a German military cohort of 534 patients, followed for up to 20 years, found that a BMI of 25 or higher did not worsen wound healing or long-term recurrence ^[5].

A large 2025 national study helps explain how weight could still matter indirectly. Across 1,662 patients at 41 Turkish hospitals, 6.26% had a recurrence within 12 months. The factors independently tied to recurrence were a previous recurrence, a postoperative wound infection and a wound that separated ^[8]. Weight was not singled out, but wound infection was, and that is where body weight shows its clearest effect.

Weight and wound problems after surgery

Wound complications after pilonidal surgery are common. A 2025 study of 774 patients across eight Western Australian hospitals found surgical site infections in 28.8% and wound breakdown in 28.4%; 27% came back to the hospital within 30 days ^[7]. The average BMI in that group was 28.58. After adjusting for other factors, being overweight carried 1.9 times the odds of a wound infection. Leaving the wound open to heal on its own carried far higher odds (6.0), and smoking raised the risk of the wound coming apart.

An earlier study of 94 patients who had excision with the wound stitched closed found an infection rate of 12.8%, with obesity and smoking as independent risk factors ^[6]. The authors went further than their data and recommended active weight loss and quitting smoking before surgery, or a different technique, for patients with obesity. That recommendation is reasonable but has never been tested in a trial.

Does losing weight help?

No study has randomized people with pilonidal disease to lose weight and then measured whether fewer of them developed it, needed surgery, or had a recurrence. What exists is a chain of indirect evidence: higher weight is associated with the disease in pooled data ^[1], overweight patients have more wound infections after surgery ^[7], and wound infections are associated with recurrence ^[8]. Each link is plausible. None proves that losing weight changes the outcome, and some studies found no weight effect at all ^[2][5].

Weight loss also changes body shape unevenly. It may make the cleft shallower and cooler, which is the proposed mechanism, but there is no data showing that it does so reliably in pilonidal patients. The practical reading is that weight is one modifiable factor, and the others with more consistent support, such as keeping the cleft free of hair and avoiding long, uninterrupted sitting, matter at least as much ^[1][3].

What about GLP-1 drugs?

There is no evidence either way. No published study has tested semaglutide, tirzepatide or any other GLP-1 drug for pilonidal disease, its recurrence or wound healing after pilonidal surgery. Any claim that these drugs treat or prevent pilonidal cysts goes beyond the research. If you are on one and need pilonidal surgery, the broader evidence on GLP-1 drugs and wound healing is the closest guide, and your surgical team should know you are taking it.

Pilonidal disease does overlap with other skin conditions where weight plays a role. The 2025 genetic analysis linked it to hidradenitis suppurativa and acne ^[1], and the evidence on weight loss and GLP-1 drugs in hidradenitis suppurativa is further along, although it should not be assumed to carry over. Intertrigo, the skin-fold rash, is another moisture-and-friction problem tied to weight.

What to expect from treatment

Treatment depends on whether the cyst is acutely infected or a long-running problem. The standard treatment for an abscess is to drain it through a cut placed to the side of the midline. In a Danish national cohort of 8,251 people treated this way, about a third needed another operation within five years (32% of men and 33% of women), so roughly two-thirds did not ^[10]. Younger patients were more likely to need more surgery: 47% of males aged 16 and under, compared with 14% of men aged 50 and over.

For chronic disease, the operation and how the wound is closed matter a great deal. A 2024 Cochrane review of 33 randomized trials with 3,667 participants found that closing the wound away from the midline, usually with a flap, probably lowers recurrence (1.5% vs. 6.8%) and wound infection (3.8% vs. 11.7%) compared with a conventional stitched midline closure, and probably shortens healing time by about five days ^[9]. Among the different off-midline flaps, no single technique clearly beat the others.

Practical guidance

• Get a painful lump at the top of the buttock crease checked. A hot, swollen, painful area with fever needs prompt care.
• Treat weight as one lever, not the main one. Hair in the cleft and long hours of sitting have at least as much support as risk factors.
• Before elective surgery, ask about infection risk. Being overweight and smoking both raise it; both can be discussed beforehand.
• Ask about the closure method. Off-midline closure is linked to fewer recurrences and infections in randomized trials.
• Do not expect a GLP-1 drug to treat the cyst. It has not been studied for this.